Position in ZTS
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$342,269
-$204,925 QoQ
Shares Held
4,763
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#263
of 509 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREENLEAF TRUST holds $3,898,206 across 6 Drug Manufacturers - Specialty & Generic names. ZTS ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
121,466 | $1,760,042 | |
| 2 | VTRS |
Viatris Inc
|
36,589 | $581,033 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,057 | $572,714 | |
| 4 | ZTS |
Zoetis Inc.
This page
|
4,763 | $342,269 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
1,993 | $335,900 | |
| 6 | ALKS |
Alkermes plc.
|
5,845 | $306,248 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $342,269 | 4,763 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $547,194 | 4,629 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $708,492 | 5,631 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $990,878 | 6,772 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,249,783 | 8,014 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,595,293 | 9,689 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,352,807 | 8,303 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $1,659,362 | 8,493 | Shares | Defined | 2024-10-22 | |
| 2024-06-30 | $1,446,342 | 8,343 | Shares | Defined | 2024-07-22 | |
| 2024-03-31 | $1,491,755 | 8,816 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $1,735,277 | 8,792 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $1,520,585 | 8,740 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $1,455,863 | 8,454 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $1,538,238 | 9,242 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,075,823 | 7,341 | Shares | Defined | 2023-01-25 | |
| 2022-09-30 | $1,033,581 | 6,970 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $1,271,642 | 7,398 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,430,077 | 7,583 | Shares | Defined | 2022-04-27 | |
| 2021-12-31 | $1,839,254 | 7,537 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,322,869 | 6,814 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,212,830 | 6,508 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $934,801 | 5,936 | Shares | Defined | 2021-04-30 | |
| 2020-12-31 | $812,274 | 4,908 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $769,962 | 4,656 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $590,505 | 4,309 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $564,558 | 4,797 | Shares | Defined | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||